METTL14 and esophageal squamous cell carcinoma: As METTL14 and OTUD7B influence the aggressive phenotypes of ESCC cells, their expression profiles could be used to predict which patients are at higher risk of developing advanced ESCC, allowing for more personalized preventive interventions.